Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Study Details page for NCT05155085 appears unchanged between the two screenshots, with no visible edits to study design, eligibility criteria, outcomes, or site list.
    Difference
    0.3%
    Check dated 2025-10-27T20:58:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:11:33.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.4%
    Check dated 2025-09-29T04:37:42.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the Back to Top link was removed; no substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-14T22:13:50.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T19:34:55.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific drug safety information, while removing previous location details and versioning information.
    Difference
    2%
    Check dated 2025-08-31T12:28:48.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.